Generali Investments Cee, Investicni Spolecnost, A.S. Novartis Ag Transaction History
Generali Investments Cee, Investicni Spolecnost, A.S.
- $970 Billion
- Q4 2024
A detailed history of Generali Investments Cee, Investicni Spolecnost, A.S. transactions in Novartis Ag stock. As of the latest transaction made, Generali Investments Cee, Investicni Spolecnost, A.S. holds 12,000 shares of NVS stock, worth $1.28 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
12,000Holding current value
$1.28 Million% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,436Shares Held
135MCall Options Held
1.12MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA12.2MShares$1.31 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.28 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$866 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$747 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$617 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $230B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...